Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Bloomberg/Bloomberg via Getty Images Thesis In my previous article about Medtronic plc (NYSE:MDT), released in I assigned a fair price of $137.6 which at the time indicated a 71.82% upside. The reason for this targets was because I updated my models following Q2 2024 released in November 30, 2023, and I explained how weight loss drugs will not affect Medtronic. This last one drove me to upgrade Medtronic from "buy" to "strong buy". So far, my thesis has materialized, since Medtronic reported Q3 2024 and it ...